ArticleTherapeutic advances in hematology2022

The impact of bortezomib-based induction in newly diagnosed multiple myeloma with chromosome 1q21 gain.

Hoi Ki Karen Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.